Acknowledgements
This original research was sponsored by ChemGenex Pharmaceuticals, Ltd (Menlo Park, CA), which is now a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd. (Frazer, PA). This study was supported in part by the M.D. Anderson Cancer Center Support Grant CA016672 (PI: Dr Ronald DePinho) from the National Cancer Institute, and the CML P01 Grant P01 CA049639 (PI: Dr Richard Champlin).
Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article online at http://10.1080/10428194.2017.1283030.